Lipella Pharmaceuticals Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Lipella Pharmaceuticals Inc. (LIPO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $274.54 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-11-14
- 2025-09-30: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month $274.54K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month |
|---|---|
| 2025-09-30 | $274.54K 10-Q · filed 2025-11-14 |